DM

Dermapharm Holding SEXETRA Dermapharm Holding Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

2.112

Small

Exchange

XETR - Xetra

View Full Company Analysis

Dermapharm Cash and equivalents

0.17 B

Last period Cash and equivalents ,EUR


What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents of Dermapharm Holding ?

Dermapharm Holding`s Cash and equivalents for the period ended 2024-06-30 are 0.17 B EUR

View Full Company Analysis